Visitors can check out the Forum FAQ by clicking this link. You have to register before you can post: click the REGISTER link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. View our Forum Privacy Policy.
Want to receive the latest contracting news and advice straight to your inbox? Sign up to the ContractorUK newsletter here. Every sign up will also be entered into a draw to WIN £100 Amazon vouchers!
Not that high that a profit of $4.90 a pill isn't attractive surely. Also after this behavior I would imagine doors would be propped open for a reputable competitor.
Depends - it will probably cost millions to set up production facilities, distribution networks etc. and from what I understand, not many of these pills are sold per year. Once you've made the investment, the marginal cost is very low, but I suspect the TCO payback period could be quite long.
However, he probably has overcooked it a bit - as it will encourage others to take a risk and enter the market - if only as a PR exercise for one of the big boys to give the impression they are weeding out the bad guys.
Depends - it will probably cost millions to set up production facilities, distribution networks etc. and from what I understand, not many of these pills are sold per year. Once you've made the investment, the marginal cost is very low, but I suspect the TCO payback period could be quite long.
However, he probably has overcooked it a bit - as it will encourage others to take a risk and enter the market - if only as a PR exercise for one of the big boys to give the impression they are weeding out the bad guys.
precisely, and of course once he stops producing then the competitor can up the price a bit.
So raise the price by 5000%, get some backlash and then cut the price to a more reasonable 100-500% increase and be called a good guy for doing.
Genius!
Saw a snippet of an interview of him on Sky News this morning. Said he justified the price rise, so he could "invest" in other treatments, thereby helping people. Jeez - the guy was so full of himself.
The company he founded in 2009 sued Shkreli last month for $65 million in damages, claiming the ex-hedge fund manager gave away Retrophin shares to friends and used the biotech firm’s assets to pay off personal debts and keep afloat his sinking investment firm, MSMB Capital Management.
A filing made in November 2014 with the U.S. Securities and Exchange Commission showed Shkreli pulled in nearly $3 million in gross proceeds as he continued selling company stock while simultaneously urging investors to buy into Retrophin — which the rapper-quoting then-CEO hyped on his Twitter account.
Shkreli began plundering Retrophin after his hedge fund — which eventually collapsed — made a “disastrous” investment in Orexigen, reported FierceBiotech.
MSMB Capital Management lost more than $7 million and went “virtually bankrupt” after the 2011 investment, but Shkreli formed a health care-focused branch of the hedge fund to keep the company afloat rather than telling investors he lost their money.
Shkreli finally told investors he was dissolving the hedge fund to focus on Retrophin — and he offered to redeem their investments in cash or stock in his new company, the website reported.
The lawsuit, however, alleges that Shkreli used a series of “extra-legal maneuvers” to essentially turn Retrophin into his personal bank — and now the company seeks every bit of money he made off the company.
The suit points out that Shkreli was accused in December 2013 of threatening a former MSMB employee and his family on social media and in written letters.
“I hope to see you and your four children homeless and will do whatever I can to assure this,” the former employee Timothy Pierotti, claimed his old boss had written in a letter to his wife.
Pierotti, who reached an out-of-court settlement of a lawsuit filed against him by Retrophin, said Shkreli contacted his children on Facebook and accused their father of betraying him and stealing $3 million from him.
Comment